SARS-CoV-2 Antibodies in the Public Hospital Staff: The Second Report of a Seroprevalence Cohort Study from Iran

Q3 Medicine
A. Amanat, K. Bagheri Lankarani, B. Honarvar, Naeimehossadat Asmarian, M. Shokripour, F. Rafiee, M. Aghazadeh, Farahnaz Izadi, N. Omidifar, Seyed Abolfazl Dorraninejad
{"title":"SARS-CoV-2 Antibodies in the Public Hospital Staff: The Second Report of a Seroprevalence Cohort Study from Iran","authors":"A. Amanat, K. Bagheri Lankarani, B. Honarvar, Naeimehossadat Asmarian, M. Shokripour, F. Rafiee, M. Aghazadeh, Farahnaz Izadi, N. Omidifar, Seyed Abolfazl Dorraninejad","doi":"10.5812/semj-121681","DOIUrl":null,"url":null,"abstract":"Background: SARS-CoV-2 is a novel virus that caused the recent global pandemic. Health care workers (HCWs), especially hospital staff, are at a higher risk of infection by this virus than the general population. In this study, anti-SARS-CoV-2 IgG antibodies were assessed in hospital workers. Methods: This prospective seroconversion-based cohort study assessed chronic immunity against covid-19 in the staff of two hospitals, the main referral hospital and a general hospital in Shiraz, south of Iran. A valid and reliable checklist was filled out for each available staff member willing to participate in this study through a face-to-face interview. Furthermore, the titer of anti-covid-19 IgG was measured by ELISA twice; in July 2020 after the second wave of COVID-19 and in February 2021 after the third wave in IRAN. Results: One hundred forty (65%) of the 214 members who participated in both stages of this consideration were from the COVID-19 referral healing center, and 74 (35%) were from the common clinic. Twelve (5.6%) of staff members had anti-SARS-CoV-2 IgG antibodies, including 10 (7.1%) from the referral healing center and 2 (2.7%) from the common healing center (P = 0.23). In the second measurement (second overview), 79 (36.9%) of members had IgG antibodies; 58 (41.4%) from the primary hospital and 21 (28.3%) from the second healing center (P = 0.039). Cruel of the IgG titer within the first study and the referral clinic was 0.8 ± 0.3 compared to 0.15 ± 0.42 within the common clinic (P = 0.001). These figures were 3.05 ± 4.58 and 1.74 ± 3.53 in both clinics and within the second overview separately (P = 0.003). IgG levels were significantly higher in the second overview compared to the first (P < 0.0001). Conclusions: During the third wave of COVID-19, a significant proportion of hospital staff developed COVID-19 IgG, especially in the referral hospitals for COVID-19. As a result of their higher and chronic exposure to COVID-19 patients than the general hospital staff, the titer of IgG in the referral hospital staff was also higher. However, the seroconversion rate between the two waves was 1.8 times in the general hospital staff compared to the referral hospital, possibly due to less conservative precautions against covid-19 among them. Even after receiving the anti-covid-19 vaccination, it is important to monitor the immunity of hospital staff to covid-19 and to adhere strictly to standard precautions.","PeriodicalId":39157,"journal":{"name":"Shiraz E Medical Journal","volume":"14 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Shiraz E Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5812/semj-121681","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Background: SARS-CoV-2 is a novel virus that caused the recent global pandemic. Health care workers (HCWs), especially hospital staff, are at a higher risk of infection by this virus than the general population. In this study, anti-SARS-CoV-2 IgG antibodies were assessed in hospital workers. Methods: This prospective seroconversion-based cohort study assessed chronic immunity against covid-19 in the staff of two hospitals, the main referral hospital and a general hospital in Shiraz, south of Iran. A valid and reliable checklist was filled out for each available staff member willing to participate in this study through a face-to-face interview. Furthermore, the titer of anti-covid-19 IgG was measured by ELISA twice; in July 2020 after the second wave of COVID-19 and in February 2021 after the third wave in IRAN. Results: One hundred forty (65%) of the 214 members who participated in both stages of this consideration were from the COVID-19 referral healing center, and 74 (35%) were from the common clinic. Twelve (5.6%) of staff members had anti-SARS-CoV-2 IgG antibodies, including 10 (7.1%) from the referral healing center and 2 (2.7%) from the common healing center (P = 0.23). In the second measurement (second overview), 79 (36.9%) of members had IgG antibodies; 58 (41.4%) from the primary hospital and 21 (28.3%) from the second healing center (P = 0.039). Cruel of the IgG titer within the first study and the referral clinic was 0.8 ± 0.3 compared to 0.15 ± 0.42 within the common clinic (P = 0.001). These figures were 3.05 ± 4.58 and 1.74 ± 3.53 in both clinics and within the second overview separately (P = 0.003). IgG levels were significantly higher in the second overview compared to the first (P < 0.0001). Conclusions: During the third wave of COVID-19, a significant proportion of hospital staff developed COVID-19 IgG, especially in the referral hospitals for COVID-19. As a result of their higher and chronic exposure to COVID-19 patients than the general hospital staff, the titer of IgG in the referral hospital staff was also higher. However, the seroconversion rate between the two waves was 1.8 times in the general hospital staff compared to the referral hospital, possibly due to less conservative precautions against covid-19 among them. Even after receiving the anti-covid-19 vaccination, it is important to monitor the immunity of hospital staff to covid-19 and to adhere strictly to standard precautions.
公立医院工作人员SARS-CoV-2抗体:伊朗血清阳性率队列研究第二份报告
背景:SARS-CoV-2是引起近期全球大流行的新型病毒。卫生保健工作者(HCWs),特别是医院工作人员,比一般人群感染这种病毒的风险更高。本研究对医院工作人员进行了抗sars - cov -2 IgG抗体检测。方法:这项基于血清转化的前瞻性队列研究评估了伊朗南部设拉子两家医院、主要转诊医院和一家综合医院的工作人员对covid-19的慢性免疫。通过面对面访谈,为每位愿意参与本研究的工作人员填写了一份有效可靠的检查表。2次ELISA检测抗covid-19 IgG滴度;在第二波COVID-19之后的2020年7月和在伊朗第三波之后的2021年2月。结果:参与这两个阶段考虑的214名成员中,有140名(65%)来自COVID-19转诊治疗中心,74名(35%)来自普通诊所。12名工作人员(5.6%)有抗sars - cov -2 IgG抗体,其中转诊愈合中心10名(7.1%),普通愈合中心2名(2.7%)(P = 0.23)。在第二次测量(第二次概述)中,79名(36.9%)成员有IgG抗体;基层医院58例(41.4%),第二康复中心21例(28.3%)(P = 0.039)。第一项研究和转诊诊所的IgG滴度平均值为0.8±0.3,而普通诊所的平均值为0.15±0.42 (P = 0.001)。两个诊所和第二次综述的数据分别为3.05±4.58和1.74±3.53 (P = 0.003)。IgG水平在第二次综述中显著高于第一次(P < 0.0001)。结论:在第三波新冠肺炎疫情期间,有相当比例的医院工作人员产生了COVID-19 IgG,特别是在转诊医院。与普通医院工作人员相比,转诊医院工作人员与COVID-19患者的长期接触较多,IgG滴度也较高。然而,与转诊医院相比,综合医院工作人员两波之间的血清转化率为1.8倍,可能是由于他们对covid-19的预防措施不太保守。即使在接种了抗covid-19疫苗后,监测医院工作人员对covid-19的免疫力并严格遵守标准预防措施也很重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Shiraz E Medical Journal
Shiraz E Medical Journal Medicine-Medicine (all)
CiteScore
1.00
自引率
0.00%
发文量
63
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信